SCHEMBL22893909

SCHEMBL22893909

c1ccc(-c2nc(-c3cccc4c3oc3ccc5ccccc5c34)nc(-n3c4ccc(-n5c6ccccc6c6ccccc65)cc4c4c5ccccc5ccc43)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33
PAX8 Q06710 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22893908 0.96 ABCG2 (0.34) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22893910 0.92 SIRT2 (0.33) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22893719 0.91 MAPT (0.36) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL24152228 0.90 MAPT (0.38) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22767160 0.90 ABCG2 (0.33) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22893718 0.90 AHR (0.34) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22893906 0.90 SIRT2 (0.34) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL25756167 0.90 SIRT2 (0.36) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22893712 0.89 SIRT2 (0.34) CYP1A1CYP1A2FYNMAPK3AHR
SCHEMBL22893720 0.89 ALDH1A1 (0.35) CYP1A1CYP1A2FYNMAPK3AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CYP1A1 2/4885CYP1A2 5/4885FYN 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.